169 related articles for article (PubMed ID: 6268288)
21. Sensitizers in radiotherapy.
Dische S
Br J Hosp Med; 1982 May; 27(5):502, 507-10. PubMed ID: 7093576
[No Abstract] [Full Text] [Related]
22. Testing of new hypoxic cell sensitizers in vivo.
Stone HB; Sinesi MS
Radiat Res; 1982 Jul; 91(1):186-98. PubMed ID: 6212963
[No Abstract] [Full Text] [Related]
23. Radiation Modifiers.
Citrin DE
Hematol Oncol Clin North Am; 2019 Dec; 33(6):1041-1055. PubMed ID: 31668205
[TBL] [Abstract][Full Text] [Related]
24. Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy.
Dische S
Radiother Oncol; 1985 Feb; 3(2):97-115. PubMed ID: 3157206
[TBL] [Abstract][Full Text] [Related]
25. Radiobiological modifiers in clinical radiation oncology: current reality and future potential.
Allison RR
Future Oncol; 2014 Dec; 10(15):2359-79. PubMed ID: 25525845
[TBL] [Abstract][Full Text] [Related]
26. Clinical trials of hypoxic cell sensitizers.
Phillips TL; Wasserman TH; Stetz J; Brady LW
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):327-34. PubMed ID: 7050034
[No Abstract] [Full Text] [Related]
27. [Recent data on biological and clinical properties of radiosensitizers (author's transl)].
Guichard M; Malaise EP
Pathol Biol (Paris); 1980 Jan; 28(1):29-42. PubMed ID: 6153787
[TBL] [Abstract][Full Text] [Related]
28. Nitroheterocyclic compounds as radiation sensitizers and bioreductive drugs.
Adams GE; Stratford IJ; Bremner JC; Edwards HS; Fielden EM
Radiother Oncol; 1991; 20 Suppl 1():85-91. PubMed ID: 2020774
[No Abstract] [Full Text] [Related]
29. Optimization of cancer radiotherapy with selective sensitizers.
Wideröe R
Strahlenther Onkol; 1987 Jun; 163(6):378-84. PubMed ID: 3603365
[TBL] [Abstract][Full Text] [Related]
30. Modification of radiation response.
Suit HD
Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):101-8. PubMed ID: 6365862
[TBL] [Abstract][Full Text] [Related]
31. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.
Yuhas JM; Yurconic M; Kligerman MM; West G; Peterson DF
Radiat Res; 1977 May; 70(2):433-43. PubMed ID: 193145
[No Abstract] [Full Text] [Related]
32. Radiosensitizers: rationale and potential.
Brown JM
Cancer Treat Rep; 1981; 65 Suppl 2():95-102. PubMed ID: 7346152
[TBL] [Abstract][Full Text] [Related]
33. [Electron acceptor compounds as radiation sensitizers of hypoxic cells in human tumors].
Kiseleva ES; Dar'ialova SL
Med Radiol (Mosk); 1984 Sep; 29(9):74-82. PubMed ID: 6384719
[No Abstract] [Full Text] [Related]
34. [Present status of radiation sensitizers--hypoxic cell radiosensitizer].
Murayama C; Mori T
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2135-41. PubMed ID: 2660744
[TBL] [Abstract][Full Text] [Related]
35. Future directions in gynecologic cancer.
Alberts DS
Semin Oncol; 1999 Apr; 26(2 Suppl 7):125-8. PubMed ID: 10348271
[TBL] [Abstract][Full Text] [Related]
36. The potential of amifostine: from cytoprotectant to therapeutic agent.
Santini V; Giles FJ
Haematologica; 1999 Nov; 84(11):1035-42. PubMed ID: 10553165
[TBL] [Abstract][Full Text] [Related]
37. Radiation modifiers: treatment overview and future investigations.
Thomas CT; Ammar A; Farrell JJ; Elsaleh H
Hematol Oncol Clin North Am; 2006 Feb; 20(1):119-39. PubMed ID: 16580560
[TBL] [Abstract][Full Text] [Related]
38. The role of amifostine as a radioprotector.
Wasserman TH; Brizel DM
Oncology (Williston Park); 2001 Oct; 15(10):1349-54; discussion 1357-60. PubMed ID: 11702962
[TBL] [Abstract][Full Text] [Related]
39. Hypoxic sensitizers--implications for radiation therapy.
Chapman JD
N Engl J Med; 1979 Dec; 301(26):1429-32. PubMed ID: 229413
[No Abstract] [Full Text] [Related]
40. Chemical modifiers of cancer treatment.
Coleman CN; Bump EA; Kramer RA
J Clin Oncol; 1988 Apr; 6(4):709-33. PubMed ID: 3282035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
